37th week of 2011 patent applcation highlights part 38 |
Patent application number | Title | Published |
20110223209 | Oxygen delivering scaffold for tissue engineering - The invention relates to compositions, implantable devices and methods related to tissue engineering. Provided is a composition comprising (i) at least one biocompatible polymer suitable for use in tissue-engineering scaffolds and (ii) at least one metal peroxide. Also provided is an implantable device comprising said composition, and methods for tissue engineering comprising the use of the device. | 2011-09-15 |
20110223210 | HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS - The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases. | 2011-09-15 |
20110223211 | PHARMACEUTICAL FORMULATIONS CONTAINING IRBESARTAN - The present invention relates to pharmaceutical compositions and formulations for the oral administration of Irbesartan, one of its pharmaceutically acceptable salts or its polymorphs, optionally combined with a diuretic and to a process for the manufacture of said composition. | 2011-09-15 |
20110223212 | DRUG ELUTING SUPERHYDROPHOBIC COATINGS - The invention describes nanotextured super hydrophobic coatings that contain active agents which can elute from the coating over a period of time. | 2011-09-15 |
20110223213 | HIGHLY PURE RANOLAZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF - Provided herein is an impurity of ranolazine, 1-[4-[2-hydroxy-3-(2-methoxy-phenoxy)-propyl]-piperazin-1-yl]-3-(2-methoxy-phenoxy)-propan-2-ol (dimer impurity-3), and process for preparing and isolating thereof. Provided further herein is a highly pure ranolazine or a pharmaceutically acceptable salt thereof substantially free of dimer impurity-3, process for the preparation, and pharmaceutical compositions comprising highly pure ranolazine or a pharmaceutically acceptable salt thereof substantially free of dimer impurity-3. | 2011-09-15 |
20110223214 | USE OF CARBOXYMETHYLCELLULOSE TO CONTROL EJECTABILITY AND SOLIDIFICATION TIME OF COMPOSITIONS COMPRISING ONE OR MORE BIORESORBABLE CERAMICS - Carboxymethylcellulose, notably sodium carboxymethylcellulose or other alkali metal or alkaline earth metal salts of carboxymethylcellulose, are employed to control solidification time of compositions comprising one or more bioresorbable ceramics, notably a hydratable calcium sulphate, in order to facilitate preparation of a ready-to-use composition for inserting into the body by injection. | 2011-09-15 |
20110223215 | PROCESS FOR MAKING A TOPICAL SCRUB - A method of producing a topical scrub includes providing a particle material suitable for producing a customized anisotropic particle; producing a plurality of customized anisotropic particles composed of the particle material, each customized anisotropic particle having a particle shape, a particle volume, and a particle composition; and dispersing the plurality of customized anisotropic particles in a fluid material to form a dispersion of customized anisotropic particles in the fluid material. At least a feature of the particle shape facilitates embedding at least a portion of the plurality of customized anisotropic particles into a topical surface by a scrubbing action. | 2011-09-15 |
20110223216 | Nanoparticles and Porous Particles and Methods of Making the Same - The subject matter disclosed herein relates to compositions and methods for engineering porous particles for aerosol formulations for pulmonary drug delivery. Certain embodiments disclosed herein further relate to methods for stabilizing suspension-based formulations in hydrofluoroalkane propellants with nanoparticles. | 2011-09-15 |
20110223217 | BLOCK COPOLYMERS AND USES THEREOF - An encoding/decoding apparatus and method using a low-density parity-check code (LDPC code) is disclosed. Basic column group information, serving as a set of information regarding positions of rows with weight 1, is extracted from a reference column in each column group of a predetermined parity-check matrix. Column group information transforms the positions of rows with weight 1 into positions whose lengths are within a required parity length. A parity-check matrix is generated according to the generated column group information. Data is encoded or decoded based on the generated parity-check matrix. | 2011-09-15 |
20110223218 | Colored Micaceous Pigments having Bismuth Oxychloride Appearance and Performance Effects - A combination pigment having a mica and/or metal oxide-coated mica substrate, an absorption colorant coating, and a waxy film bonding the absorption colorant coating to the substrate. | 2011-09-15 |
20110223219 | Probiotic Color Cosmetic Compositions And Methods - A probiotic color cosmetic composition comprising at least one extract from a probiotic microorganism; at least one non-clay lamellar phyllosilicate mineral particulate; and at least one anti-inflammatory ingredient present in an amount sufficient to inhibit one or more of the pathways that contribute to skin inflammation; and a method for treating skin for improvement by applying to skin in need of such improvement the composition of the invention. | 2011-09-15 |
20110223220 | DISPERSIONS OF ENCAPSULATED PARTICLES AND METHODS FOR THEIR PRODUCTION AND USE - Disclosed are dispersions of encapsulated particles and methods for their production and use. These dispersions include encapsulated particles and a liquid medium in which the encapsulated particles are dispersed. The encapsulated particles include a carrier particle and an encapsulant deposited on the carrier particle. The liquid medium and the encapsulant are selected so as to be capable of reacting with each other to form a reaction product having a boiling point of no more than 300° C. at atmospheric pressure. | 2011-09-15 |
20110223221 | STABILIZATION PROCESSES OF CATION RADICALS OF PHENOTHIAZINIC COMPOUNDS, COSMECEUTICAL FORMULATIONS AND METHODS FOR SKIN DISEASES AND DISTURBANCES PREVENTION - The present invention relates to processes of stabilization of cation radicals from one or more phenothiazinic compounds or derivatived compounds thereof. Another embodiment of the present invention relates to cosmeceutical formulations comprising one or more phenothiazinic compounds or derivatived compounds thereof, in combination with cosmeceutically acceptable excipients. The invention also relates to uses of one or more phenothiazinic compounds or derivatived compounds thereof, i the preparation of cosmeceutical formulations for the prevention of skin diseases and disturbances. Methods for prevention of skin diseases and disturbances are also disclosed by the present invention. Particularly, the embodiments of the present invention employ the cited one or more phenothiazinic compounds o derivatived compounds thereof in the form of their stabilized cation radicals. | 2011-09-15 |
20110223222 | Antiperspirant Compositions and Methods for Reducing Perspiration in Humans - A new method for inhibiting or reducing perspiration and preventing body unpleasant odors is provided. Alternative antiperspirant actives capable of activating TRPM8 channels are topically applied, leading to inhibition or reduction of sweat production. Preferred agent is a TRPM8 agonist, derived or not from essential oils of plants. Cosmetic or pharmaceutical product comprising the TRPM8 agonist and the use of TRPM8 agonists as antiperspirant active are also claimed. | 2011-09-15 |
20110223223 | POWDER COSMETIC MATERIAL - The invention aims to provide a powder cosmetic in which the powder component causes no aggregation and the surface powder component causes no caking in press processing even if a large amount of oily component is contained therein. Said powder cosmetic is characterized by comprising oblate cellulose particles and an oily component. | 2011-09-15 |
20110223224 | COSMETIC COMPOSITION INCLUDING MICROBEADS - A cosmetic composition, microbeads to be added into a cosmetic carrier for said composition, methods for making the same, and the uses thereof. The composition comprises microbeads having one or more concentric coating layers around a core, each concentric coating layer including a solid phase and a binder, at least one of the concentric coating layers includes a pigment, and the composition also comprises a cosmetic carrier. The invention is particularly useful as a make-up product. | 2011-09-15 |
20110223225 | SOLID OIL POWDERS - The present invention relates in general to the field of oil powders. In particular, the present invention relates to an oil composition that is in powder form at room temperature. One embodiment of the present invention is a solid oil powder that has a very high oil content. | 2011-09-15 |
20110223226 | SHELF STABLE CAPSULES - A capsule slury including at least one coacervated capsule and at least 10 wt % humectant is disclosed. The humectant may be sorbitol, glycerin, polyethylene glycol, propylene glycol, xylitol, erythritol and/or betaine. | 2011-09-15 |
20110223227 | Method for preventing direct touch contact with a germ-laden contact surface - A method for using a commercially-available silver-coated anti-microbial wound dressing (sold under the trademark Silverlon) as a protective guard to prevent direct touch-contact between the hand of an individual and a contact surface. The protective guard establishes a barrier to prevent the spread of germs and potentially disease-causing bacteria from the contact surface to the individual's hand. The protective guard can be carried in the individual's hand and simply moved against the contact surface. Alternatively, the protective guard an be attached to, bent around or folded over the contact surface to prevent direct touch-contact therewith. | 2011-09-15 |
20110223228 | Repellant for Ground Rooting Animals - A repellant composition for ground rooting animals is disclosed that includes a limestone carrier of capsicum powder and a limestone sorbent for castor oil that each has a limestone coating bound to them by a binding agent. The limestone sorbent is porous and provides a long-sustained release of repellant elements from the composition, while providing a composition that is dry to the touch. The repellant composition is spread on the ground, drenched to work it into the ground and then allowed to dry. The composition maintains effectiveness for several months while being beneficial to soil. | 2011-09-15 |
20110223229 | IMMOBILISED BIOLOGICAL ENTITIES - There is described inter alia a medical device having a surface which comprises a coating layer, said coating layer being a biocompatible composition comprising an anti-coagulant entity capable of interacting with mammalian blood to prevent coagulation or thrombus formation, which anti-coagulant entity is covalently attached to said surface through a linker comprising a thioether. | 2011-09-15 |
20110223230 | HYDROGEL FORMULATIONS - A polymeric prodrug composition including a hydrogel, a biologically active moiety and a reversible prodrug linker. The prodrug linker covalently links the hydrogel and the biologically active moiety at a position and the hydrogel has a plurality of pores with openings on its surface. The diameter of the pores is larger than that of the biologically active moiety at least at all points of the pore between at least one of the openings and the position of the biologically active moiety. | 2011-09-15 |
20110223231 | FRAGMENTED POLYMERIC COMPOSITIONS AND METHODS FOR THEIR USE - Cross-linked hydrogels comprise a variety of biologic and non-biologic polymers, such as proteins, polysaccharides, and synthetic polymers. Such hydrogels preferably have no free aqueous phase and may be applied to target sites in a patient's body by extruding the hydrogel through an orifice at the target site. Alternatively, the hydrogels may be mechanically disrupted and used in implantable articles, such as breast implants. When used in vivo, the compositions are useful for controlled release drug delivery, for inhibiting post-surgical spinal and other tissue adhesions, for filling tissue divots, tissue tracts, body cavities, surgical defects, and the like. | 2011-09-15 |
20110223232 | DRUG-RELEASE COMPOSITION HAVING A THERAPEUTIC CARRIER - The invention is generally directed to a drug-release composition that contains drug-linker-drug compound that is combined with another therapeutic agent that can be an antirestenotic agent. The therapeutic agent can be partially bound to the drug-linker-drug compound, miscible with the drug-linker-drug compound, combined with the drug-linker-drug compound at various ratios, and tuned to control the release of drugs to a tissue in need thereof. | 2011-09-15 |
20110223233 | MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT - A drug delivery device that includes a capsule for implantation into the body; the capsule further includes a reservoir for containing a substance such as a therapeutic agent, at least one port for allowing the substance to diffuse from or otherwise exit the reservoir, and a nanopore membrane in communication with the capsule at or near the exit port for controlling the rate of diffusion of the substance from the exit port. The device also includes an optional screen for providing structural stability to the nanopore membrane and for keeping the pores of the nanopore membrane clear. One embodiment of the drug delivery device includes an osmotic engine internal to the device for creating fluid flow through the device. | 2011-09-15 |
20110223234 | Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof - A palatable, edible soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The edible soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the edible soft chews do not require the use of heat or the addition of water during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture. | 2011-09-15 |
20110223235 | SELEGILINE-CONTAINING ADHESIVE PREPARATION - The present invention provides an adhesive preparation, which includes a backing and a pressure-sensitive adhesive layer formed on at least one side of the backing, the pressure-sensitive adhesive layer containing (−)-(R)—N,α-dimethyl-N-2-propynylphenethylamine and/or a pharmaceutically acceptable salt thereof, a pressure-sensitive adhesive and one or two or more stabilizers selected from the group consisting of 2-mercaptobenzimidazole, sodium sulfite, butylhydroxyanisole and butylhydroxytoluene. | 2011-09-15 |
20110223236 | SELEGILINE-CONTAINING ADHESIVE PREPARATION - The present invention provides an adhesive preparation, which includes a backing and a pressure-sensitive adhesive layer formed on at least one side of the backing, the pressure-sensitive adhesive layer containing (−)-(R)—N,α-dimethyl-N-2-propynylphenethylamine and/or a pharmaceutically acceptable salt thereof, a pressure-sensitive adhesive and a component which is liquid at 25° C. and has two or more ester bonds in one molecule thereof. | 2011-09-15 |
20110223237 | SELEGILINE-CONTAINING ADHESIVE PREPARATION - The present invention provides an adhesive preparation, which includes a backing and a pressure-sensitive adhesive layer formed on at least one side of the backing, the pressure-sensitive adhesive layer containing (−)-(R)—N,α-dimethyl-N-2-propynylphenethylamine and/or a pharmaceutically acceptable salt thereof, a pressure-sensitive adhesive, an antioxidant and a metal hydroxide. | 2011-09-15 |
20110223238 | Bisbenzamidines for the Treatment of Pneumonia - A method of combating infectious agents, such as | 2011-09-15 |
20110223240 | COMPOUNDS FOR REVERSING AND INHIBITING PROTEIN AGGREGATION, AND METHODS FOR MAKING AND USING THEM - The invention provides compositions for increasing the clearance of protein aggregates, and pharmaceutical compositions comprising them, and methods for making and using them, including methods for accelerating protein aggregate clearance in the CNS, e.g., for treating diseases that are characterized by protein aggregation—including some degenerative neurological diseases such as Parkinson's disease. In one aspect, the compositions of the invention specifically target synuclein, beta-amyloid and/or tau protein aggregates, and the methods of the invention can be used to specifically prevent, reverse, slow or inhibit synuclein, beta-amyloid and/or tau protein aggregation. In alternative embodiments, the compositions and methods of the invention, are used to treat, prevent, reverse (partially or completely) or ameliorate (including slowing the progression of) degenerative neurological diseases related to or caused by protein aggregation, e.g., synuclein, beta-amyloid and/or tau protein aggregation. In one aspect, compositions and methods of this invention are used to treat, prevent or ameliorate (including slowing the progression of) Parkinson's disease, fronto-temporal dementia (FTD), Alzheimer's Disease (AD), Lewy body disease (LBD) and Multiple system atrophy (MSA). | 2011-09-15 |
20110223241 | COMBINATION METHODS AND COMPOSITIONS - Compositions which comprise a liposomal water-soluble camptothecin and optionally a liposomal fluoropyrimidine in combination with a vascular epithelial growth factor (VEGF) inhibitor such as cetuximab or an epidermal growth factor receptor (EGFR) inhibitor such as bevacizumab are useful in achieving enhanced therapeutic effects for the treatment of cancer. | 2011-09-15 |
20110223242 | NANOPARTICLES CONTAINING A PEPTIDE, VECTORS CONTAINING SAID NANOPARTICLES, AND PHARMACEUTICAL USES OF SAID NANOPARTICLES AND VECTORS - The invention relates to nanoparticles comprising a matrix containing at least one polysaccharide as well as the peptide P140 having the sequence SEQ ID NO: 1 or an analog thereof, said polysaccharide preferably being a polysaccharide bearing one or more negatively-charged functional groups. The invention also relates to a carrier for oral administration that comprises a carrier including at least one nanoparticle as defined above and either containing or not containing a dispersant. | 2011-09-15 |
20110223243 | ARTIFICIAL OXYGEN CARRIERS AND USE THEREOF - The invention relates to dispersions of artificial oxygen carriers, wherein the dispersions contain capsules with reversible oxygen storage capacity, the capsules comprising an oxygen-permeable capsule material, that contains and/or encloses fluorinated, particularly perfluorinated hydrocarbons, preferably perfluorocarbons. The dispersions are particularly suitable as a blood substitute, preferably for the purpose of transfusion, e.g. in states of blood loss of the human or animal body, in particular following surgical interventions, accidents, injuries etc, or for the prophylactic treatment and/or treatment by therapy of ischaemic states or states following a reperfusion. | 2011-09-15 |
20110223244 | ALCOHOL RESISTANT ENTERIC PHARMACEUTICAL COMPOSITIONS - Pharmaceutical formulations that resist ethanol-induced dose dumping and methods of use thereof. | 2011-09-15 |
20110223245 | CONTROLLED-RELEASE FORMULATIONS OF PRAMIPEXOLE - A controlled-release pharmaceutical formulation, comprising pramipexole or a pharmaceutically acceptable salt of pramipexole, colloidal silicone dioxide, and glyceryl behenate. | 2011-09-15 |
20110223246 | DOCOSAHEXAENOIC ACID BOUND IN PHOSPHOLIPIDS AND METHOD OF RECOVERING SAME FROM A NATURAL SOURCE - Medicaments and therapeutic compositions contain (1) phospholipids having 4,7,10,13,16,19-docosahexaenoic acid covalently bound thereto and (2) at least one omega-3 polyunsaturated fatty acid, or at least one pharmaceutically acceptable omega-3 polyunsaturated fatty acid derivative or mixtures thereof, wherein about 25% of the total 4,7,10,13,16,19-docosahexaenoic acid moieties in the composition are covalently bound to phospholipids, and wherein components (1) and (2) are present in amounts effective to support overall neurological health in a subject. | 2011-09-15 |
20110223247 | PHARMACEUTICAL COMPOSITIONS FOR RELEASE CONTROL OF METHYLPHENIDATE - Disclosed is a pharmaceutical composition for release control comprising a plurality of particles for release control. The plurality of particles for release control comprise a core material containing methylphenidate and a polymer coating layer for release control formed on the core material. The plurality of particles for release control are divided into two or more groups based on the average thickness of the polymer coating layer for release control. The particle groups are identical in terms of the composition of the polymer in the polymer coating layer, but are different in terms of the average thickness of the coated layer. The pharmaceutical composition for release control according to the present invention may control the release pattern of methylphenidate contained in the core material as desired, and can be used as an oral formulation in a variety of forms such as orally disintegrating tablets, etc. | 2011-09-15 |
20110223248 | METHODS AND COMPOSITIONS FOR TREATING LACTOSE INTOLERANCE - The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a lactose composition optionally in combination with effective amount of a probiotic, prebiotic, or both. | 2011-09-15 |
20110223249 | EXTENDED RELEASE COMPOSITIONS COMPRISING MYCOPHENOLATE SODIUM AND PROCESSES THEREOF - Extended release pharmaceutical compositions comprising mycophenolate sodium as the active agent, wherein the said composition exhibits a characteristic release profile when subjected to in-vitro dissolution study, and wherein said mycophenolate sodium is released in a sustained manner in-vivo for a prolonged duration in such quantities that substantially alleviates or at least reduces the chances of causing any associated gastrointestinal side effect(s) without compromising the bioavailability of the said active agent are provided. The present invention also provides process of preparing dosage form compositions and prophylactic and/or therapeutic methods of using such dosage form. The compositions of the present invention are useful for the management such as prophylaxis, amelioration and/or treatment of immunosuppressant indicated disease(s)/disorder(s) especially for the treatment or prevention of organ, tissue or cellular allograft or xenograft rejection, e.g. after transplant, or the management of immune-mediated diseases (autoimmune diseases). | 2011-09-15 |
20110223250 | MULTI-VITAMIN AND MINERAL NUTRITIONAL SUPPLEMENTS - The invention provides a nutritional supplement which includes micronutrients to facilitate reduction of cholesterol, and/or reduction of homocystein and/or reduction of low-density lipoprotein-cholesterol (LDL-C) oxidation in humans. In one embodiment the supplement is a multi-vitamin, a mineral supplement which includes at least one component known to reduce cholesterol. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized tablet and a method for reducing blood cholesterol in humans. | 2011-09-15 |
20110223251 | BACTERIAL COMPOSITION - The present invention relates to a bacterial composition which has a long shelf-life, and a process for producing such compositions. The invention further relates to food products comprising the bacterial composition. | 2011-09-15 |
20110223252 | ELECTROLYTE PURGATIVE - The invention relates to compositions for use in purgatives, to purgatives comprising such compositions, and to methods for inducing purgation of the colon. The composition may comprise at least one water-soluble sodium salt; at least one water-soluble minimally degradable sugar in an amount, by weight, of from about 1 to about 3 times the weight of sodium ions in said composition; at least one water-soluble potassium salt in an amount, by weight, of from about 0.05 to about 1 time the weight of said sodium salt in said composition; and at least one water-soluble magnesium salt, wherein the weight of magnesium ions in said composition is from 0.1 to about 10 times the weight of sodium ions in said composition. | 2011-09-15 |
20110223253 | PHYSICALLY STABILIZED BIODEGRADABLE OSTEOCHONDRAL IMPLANT AND METHODS FOR ITS MANUFACTURE AND IMPLANTATION - A physically stabilized biodegradable osteochondral implant includes a porous matrix element of a resilient material and blood coagulated in vitro in open pores of the element. Also disclosed is a method of manufacture of the implant and a method of restoring a damaged articular surface by use of the implant. | 2011-09-15 |
20110223254 | FUNCTIONALIZED DIPHENOLICS AND ABSORBABLE POLYMERS THEREFROM - The present invention relates to dephenolic compounds, an example of which is shown below, which are functionalized, and polymers formed from the same. | 2011-09-15 |
20110223255 | IMPLANTABLE PRODUCTS COMPRISING NANOPARTICLES - The present disclosure relates to nanoparticle-containing implantable and preferably biodegradable medical products and their use for the thermotherapeutic after-treatment after surgical removal of tumors and cancerous ulcers. | 2011-09-15 |
20110223256 | Method For Stabilizing Flavonoid Aqueous Dispersion - A method for suspending microparticulated water insoluble bioactive compound in a beverage by incorporating solubilized or dispersed microparticulated compound and at least one dispersion stabilizer into a beverage. A composition comprising solubilized or dispersed microparticulated water insoluble bioactive compound and a dispersion stabilizer agent. | 2011-09-15 |
20110223257 | RELEASABLE FUSOGENIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS - The present invention relates to releasable fusogenic lipids and nanoparticle compositions containing the same for the delivery of oligonucleotides and methods of modulating gene expression using the same. In particular, this invention relates to releasable fusogenic lipids containing an imine linker and a zwitterionic moiety. | 2011-09-15 |
20110223258 | Ferric Phosphate Based Composition, the Preparation and Use Thereof - The invention deals with an ferric phosphate based composition, in order to obtain which 100 mass fractions of orthophosphoric acid, 10-20 mass fractions of iron(III) oxide, 5-10 mass fractions of powdery aluminium oxide and 100 mass fractions of water are mixed, whereas the reaction takes place within a temperature range of 60-70° C. and at least one nanopowder from among silver, copper or flint is added to the mixture in the amount of 0.5 mass fractions, The ferric phosphate based compositions can be used for the bio- and fire protection of timber, as an antibacterial disinfectant, as well as a rust converter for the rust-inhibiting of metals. | 2011-09-15 |
20110223259 | ANTI-VIRAL PHARMACEUTICAL COMPOSITIONS - The present invention provides antiviral compositions that comprise one or more of an ionic multivalent metal component, a cationic polymer, and a cationic surfactant. The present invention also provides methods for making and using such antiviral compositions. | 2011-09-15 |
20110223260 | Mazindol Combindation In The Treatment Of Attention Deficit/Hyperactivity - The present invention relates to the filed of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered as monotherapy or in combination with one or more compounds, including psychostimulants, for the indication of ADHD and associated or co-morbid symptoms. | 2011-09-15 |
20110223261 | STABLE CLEANSER COMPOSITIONS CONTAINING SULFUR - The present invention is a composition, preferably a cleanser, comprising sulfur, sodium sulfacetamide and at least one emulsifier with a low HLB number. These compositions are stable and may include moisturizers and humectants. Use of these compositions include treatments for acne rosacea, acne vulgaris and other skin disorders. | 2011-09-15 |
20110223262 | Method of Enhancing Biological Activity of Plant Extracts - The present invention relates to a method of modulating a selected biological activity of a naturally occurring material having one or more biological activities in an extract of the naturally occurring material, the method comprising incubating the extract in a medium in the presence of an aerobically metabolizing microorganism, under suitable aerobic conditions, for a period of time sufficient to modulate the selected activity with respect to baseline activity of the unincubated extract. The invention also relates to the bioconverted material so prepared, and the use of same in cosmetic or pharmaceutical compositions. | 2011-09-15 |
20110223263 | ANTIOXIDANT COSMETIC COMPOSITION CONTAINING EXTRACT OF PROCESSED PEONY, POLYGONATI RHIZOMA OR LILY - The present invention relates to an antioxidant cosmetic composition, and more particularly to an antioxidant cosmetic composition containing, as an active ingredient, either an extract of at least one of peony, Polygonati rhizoma and lily, processed using a medicinal herb processing technique, or a mixture of said extract and an extract of at least one of unprocessed peony, Polygonati rhizoma and lily. | 2011-09-15 |
20110223264 | Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE Proteins - The invention relates to a substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins. | 2011-09-15 |
20110223265 | ANTIOXIDANT COMPOSITION CONTAINING EXTRACT OF PROCESSED CHRYSANTHEMUM INDICUM OR CITRUS UNSHIU PEEL - The present invention relates to an antioxidant cosmetic composition, and more particularly to an antioxidant cosmetic composition containing, as an active ingredient, either an extract of at least one of | 2011-09-15 |
20110223266 | BEVERAGE AND MEDICAMENT CONTAINING BAMBOO EXTRACT AS A MAIN INGREDIENT - The present invention relates to a beverage containing bamboo extract as a main ingredient, for details, a beverage containing bamboo extract as the main ingredient, which is useful for amelioration of diabetes, cancer, life-style related diseases or the like. A beverage characterized in containing, as the main ingredient, bamboo extract obtained through the process comprising the steps by immersing bamboo in water and extracting the bamboo extract with heating the water to 95° C. or higher and maintaining the temperature for a period of 2 hr 45 min to 3 hr 15 min. | 2011-09-15 |
20110223267 | COMPOSITIONS OF BAKUCHIOL AND METHODS OF MAKING THE SAME - The present invention provides compositions of bakuchiol (UP246) having low levels of impurities, particularly furanocoumarin impurities. The present invention further provides improved methods for the isolation, purification and analysis of compositions of bakuchiol. Finally, the present invention provides methods for using the purified bakuchiol compositions and formulations thereof for the prevention and treatment of various diseases and conditions mediated by cyclooxygenase (COX), lipoxygenase (LOX), minor inflammatory conditions and various microbial infections. The methods of this invention are comprised of administering to a host in need thereof an effective amount of the composition of this invention together with a pharmaceutically acceptable carrier. | 2011-09-15 |
20110223268 | COSMETIC COMPOSITION CONTAINING EXTRACTS OF ADENOPHORA TRIPHYLLA VAR. JAPONICA HARA, ANGELICA TENUISSIMA AND MEDICINAL HERBS - Disclosed herein is a cosmetic composition containing, as an active ingredient, a mixture of extracts of honey-roasted | 2011-09-15 |
20110223269 | AGENT FOR TREATING EYE DISEASES - An agent for treating various kinds of diseases which contains at least one selected from the group consisting of sexual steroid hormone such as estrogen or its metabolites, its derivative, structural analogues thereof, estrogen acting substance or SERM non-feminizing estrogen (non-hormonal estrogen), and an activator of sirtuin and has a form of eye drops or eye washes, oral preparation, etc. An agent for treating eye diseases which has excellent treatment effects, reduced in side action can be provided. | 2011-09-15 |
20110223270 | USES OF CURCULIGO LATIFOLIA (C. LATIFOLIA) EXTRACTS - The present invention relates to | 2011-09-15 |
20110223271 | PHYTOCOMPLEX FROM BERGAMOT FRUIT, PROCESS OF MANUFACTURE AND USE AS DIETARY SUPPLEMENT AND IN THE PHARMACEUTICAL FIELD - The invention relates a phytocomplex obtained from the bergamot fruit albedo (Citrus Bergamia Risso & Poiteau), the production thereof and the use thereof, in particular under the form of dry extract, to be used as normalizer of the metabolic unbalances of lypemic and glycemic type, in the treatment of the cutaneous diseases with inflammatory or degenerative character, as painkilling/anti-inflammatory agent, as antineoplastic agent and dietary supplement. | 2011-09-15 |
20110223272 | APPARATUS FOR SLIPFORM CASTING - Apparatus for slipform casting particularly of a moulded concrete structure including a slipform yoke having at least one pair of yoke legs in opposite disposal, at least one pair of form halves connected to the yoke legs between which form halves concrete is poured and at least one jack pipe interacting with the yoke, wherein the jack pipe is hollow. | 2011-09-15 |
20110223273 | MULTI-AXIS INJECTION MOLDING APPARATUS - A multi-axis injection molding apparatus is provided with a fixed platen, a movable platen, a plurality of injection devices, and an intermediate platen disposed between a fixed mold and the fixed platen. The intermediate platen includes a runner adapted to supply a molten resin from a single in-line injection apparatus to the plurality of injection devices. | 2011-09-15 |
20110223274 | RECIPROCATING APPARATUS, METHOD OF CONTROLLING RECIPROCATING APPARATUS, AND INJECTION MOLDING APPARATUS - A reciprocating apparatus comprises a reciprocating member, a drive mechanism, an input device, a work-switch position calculating unit configured to calculate a work-switch position for the drive mechanism, a direction-switch position calculating unit configured to calculate a direction-switch position, a remaining-distance calculating unit configured to calculate a remaining distance that is a difference between the direction-switch position calculated by the direction-switch position calculating unit and a direction-switch position input at the input device, a target direction-switch position calculating unit configured to add the remaining distance, to the direction-switch position calculated by the direction-switch position calculating unit, thereby to calculate a target direction-switch position, and a corrected position calculating unit configured to calculates a corrected work-switch position for the drive mechanism so that the drive mechanism may cause the reciprocating member to start moving in the opposite direction at the target direction-switch position calculated by the target direction-switch position calculating unit. | 2011-09-15 |
20110223275 | DEVICE FOR ATTACHING A MOULD BASE ON A MEDIUM - A removable device ( | 2011-09-15 |
20110223276 | DOSING DEVICE - The invention relates to a metering device for supplying devices such as, for example, extruders, injection molding machines or the like with bulk materials such as pellets, chips, granules, powders, flakes, grains, flour or the like, having a housing. It is demonstrated how an optimally smooth passage of such bulk materials through such a metering device is possible without there being any possibility of nests forming and throughflow being hindered in the feed channel. | 2011-09-15 |
20110223277 | Die Plate - A die plate for the rotor of a rotary tablet press comprising a plurality of die holes, with dies provided therein, arranged distributed in the circumferential direction of the die plate, and between every two adjacent die holes radially running bores, in each of which a fastening device is disposed for fastening the dies, characterized in that at least one fastening device comprises two clamping elements disposed opposite each other in a radial bore, and a tensioning device, wherein the clamping elements can be tensioned against each other in the radial direction using the tensioning device, wherein the clamping elements are pressed against the dies adjacent to the radial bore. | 2011-09-15 |
20110223278 | APPARATUS FOR EMBOSSING A WEB - An apparatus for embossing a web having a static gas pressure plenum and a forming structure disposed in contact to the static gas pressure plenum. The static gas pressure plenum provides a static gas pressure of from about 0.1 MPa to about 25 MPa. | 2011-09-15 |
20110223279 | NANO IMPRINT MASTER AND METHOD OF MANUFACTURING THE SAME - A nano imprint master and a method of manufacturing the same are provided. The method includes: implanting conductive metal ions into a substrate including quartz to form a conductive layer inside the quartz substrate; coating a resist on the quartz substrate in which the conductive layer is formed, to form a resist coating layer; exposing the resist coating layer to an electron beam to form micropatterns; etching the quartz substrate by using the resist coating layer, in which the micropatterns are formed, as a mask; and removing the resist coating layer to obtain a master in which micropatterns are formed. | 2011-09-15 |
20110223280 | Basic Water - The basic water can, for example, be used as a de-acidification drink and/or as a pH-stabilizing medium. The lye is preferably manufactured with an electrolysis method or with a membrane electrolysis method. Caustic soda lye (NaOH), caustic potash lye (KOH), or calcium hydroxide solution (Ca(OH) | 2011-09-15 |
20110223281 | EFFECTS OF A DECAFFEINATED GREEN COFFEE EXTRACT ON BODY WEIGHT CONTROL BY REGULATION OF GLUCOSE METABOLISM - A method of controlling body weight in humans by administering an amount of decaffeinated green coffee extract effective to treat a subject. A preferred green coffee extract contains a ratio of 4-caffeoylquinic acid (4-CQA) to total chlorogenic acids (tCGA) (5-CQA/tCGA) of from about 0.1 to about 0.2. More preferably, the green coffee extract comprises from about 6% to about 8% of 4-caffeoylquinic acid and has a total chlorgenic acid concentration that exceeds about 45%. A preferred method of administration consists of administering the green coffee extracts is a dosage of about 200 mg twice a day prior to meals on an empty stomach. | 2011-09-15 |
20110223282 | NUTRITIONAL COMPOSITION WITH ANTI-REGURGITATION PROPERTIES - A nutritional composition for the management of regurgitation in infants which composition includes which composition includes a protein source consisting essentially of partially hydrolysed proteins, a lipid source and a carbohydrate source comprising a starch selected from cereal starch or potato starch wherein the starch amounts to between 18 to 25% of the nutritional composition on a dry weight basis. | 2011-09-15 |
20110223283 | TRANSFER METHOD - A method of glycosylating a lipid having a free hydroxyI group, the method comprising contacting said lipid with a source of monosaccharide moiety and a transglycosidase enzyme, is disclosed. In particular, a method for in situ production of the glycosylated lipid in a food product is disclosed. | 2011-09-15 |
20110223284 | Compositions and Methods for Producing Fermentation Products and Residuals - The present invention provides compositions and methods designed to increase value output of a fermentation reaction. In particular, the present invention provides a business method of increasing value output of a fermentation plant. The present invention also provides a modified fermentation residual of higher commercial value. Also provided in the present invention are complete animal feeds, nutritional supplements comprising the subject ferment residuals. Further provided by the present invention is a method of performing fermentation, a modified fermentative microorganism and a genetic vehicle for modifying such microorganism. | 2011-09-15 |
20110223285 | METHOD FOR CONTROLLING PRODUCT CHARACTERISTICS IN THE MANUFACTURE OF MEAT PRODUCTS - The invention relates to a method for controlling the product characteristics during the production of foodstuffs, which are attributable to the product groups raw and cooked sausages, pies, cooked meat products or the like, especially to obtain a spreadable or cuttable product. According to the invention, during the production of raw sausage usual starting materials are salted, mixed and coarsely pre-minced, however, not in a deep-frozen state. Then this mixture is subjected to a fermentation and acidification. According to the invention, a high-pressure treatment is performed subsequently so as to allow a protein coagulation and simultaneously inactivate microorganisms, while the mechanically separated raw meat materials remain separated. Then a fine mincing and a filling are performed. | 2011-09-15 |
20110223286 | METHOD OF REDUCING VOIDS IN DOUGH - Methods of making dough pieces that can be baked to form baked bread articles having a reduced number of voids in the crumb are provided. | 2011-09-15 |
20110223287 | METHOD FOR PRODUCING YEAST WITH HIGH GLUTAMIC ACID CONTENT - Provided is a method for producing a yeast containing glutamic acid at a high concentration. In the method for culturing a yeast, a yeast in a stationary growth phase is subjected to liquid culture under the conditions that the pH of a liquid medium is 7.5 or higher and lower than 11. After the pH of the liquid medium for the yeast in a stationary growth phase is adjusted to 7.5 or higher and lower than 11, the yeast is further cultured, whereby a yeast with a high glutamic acid content can be produced. In the invention, as the yeast, | 2011-09-15 |
20110223288 | METHOD FOR PRODUCING ALANINE-RICH YEAST - The present invention relates to a method for producing an alanine-rich yeast containing alanine at a high concentration and includes: a method involving liquid-culturing a yeast in a stationary phase of proliferation under the condition that the pH of a liquid medium is ≧7.5 and <11; a method for producing an alanine-rich yeast by adjusting the pH of a liquid medium to ≧7.5 and <11, and then culturing the yeast in this pH range; a method of producing an alanine-rich yeast, wherein the yeast is | 2011-09-15 |
20110223289 | EXTRUSION-STABLE POLY-UNSATURATED FATTY-ACID COMPOSITIONS FOR FOOD PRODUCTS - The invention relates to the use of encapsulated particles containing PUFAs embedded in a protein matrix for the preparation of extruded food, to the PUFA-supplemented extruded food and to the process for the preparation thereof. | 2011-09-15 |
20110223290 | Ice Cream Cone Stabilizer and Method - A stabilizer for ice cream cones is a generally flat elongated body with a tapered tip at one end and a rounded or novelty decoration at the other end. The center of the stabilizer may be flared to increase the surface area of the stabilizer. In use, the stabilizer is inserted into the ice cream within the cone so that the tapered end approaches the base of the inside of the cone, while the other end extends above the top of the ice cream. The stabilizer acts to prevent sideways movement of the ice cream that is above the top edge of the cone, and thus reduces the risk of the ice cream falling off the cone. | 2011-09-15 |
20110223291 | NOVELTY CANDY DISPENSER 2 - A candy food product comprises a candy pop having a hard candy rod formed and supported at a support base, and a dispenser shaped as a personal electronic device for storing a plurality of confectionary powders in a plurality of confectionary compartments. A lid selectively movable between an open and closed position sealingly engages the dispenser. A receptacle is formed in the dispenser proximate to the confectionary compartments and receives the candy pop therein. | 2011-09-15 |
20110223292 | FROZEN CONFECTION HOLDER - The present invention relates generally to a system and apparatus for holding frozen confections, and for catching and storing the drips or melting confection that results therefrom. The present invention includes a handle and a bowl or funnel-shaped drip catching member, the drip catching member including at least one drip slit or opening for allowing drips to migrate from the drip catching member down into an internal reservoir located within the handle. The internal reservoir stores the drips until emptied. The drip slits or openings are positioned within a drip-pass-through region of the drip catching member for allowing the drips to more efficiently migrate into the reservoir regardless of the angle at which the frozen confection holder is held. | 2011-09-15 |
20110223293 | Method for Shaping a Food Product by Cryoextrusion Employing Predictive Temperature Regulation - The subject of the invention is a method for shaping at least one food product by cryoextrusion, the extruder being provided with a double-walled jacket surrounding the extrusion screw and through which jacket a coolant flows, this jacket consisting of a single module or several independent modules, the cryoextrusion being temperature-regulated on the basis of a curve, determined for said product to be cryoextruded, representing, plotted on the X-axis, the difference D between the actual temperature of the product and the desired temperature setting for the product at the exit and, plotted on the Y-axis, the setting to be applied for the gas temperature at the exit of the module or modules, the curve being split into three linear zones: an abrupt (steep-slope) zone, around a difference D close to 0, surrounded by two quasi-plateau zones. | 2011-09-15 |
20110223294 | METHOD OF TREATING FOOD AND FOOD OBTAINED BY THIS METHOD - A method of treating food capable of easily softening or pulverizing food in a short time without losing nutrients is provided. A shock wave (SW) generated in a shock wave source is applied to food such as an apple or tea leaves to soften or pulverize the food. A large mechanical load is not necessary, so the food is easily softened or pulverized. Moreover, it is not necessary to heat the food, so the food is softened or pulverized in a short time without losing nutrients in the food due to heat during heating. | 2011-09-15 |
20110223295 | Preparation of soy protein isolate using calcium chloride extraction ("S703 CIP") - A soy protein product having a protein content of at least about 60 wt % (N×6.25) d.b., preferably an isolate having a protein content of at least about 90 wt % (N×6.25) d.b., is formed by a procedure in which soy protein is extracted from a soy source material using an aqueous calcium chloride solution at low pH, generally about 1.5 to about 5, and separating the resulting aqueous soy protein solution from residual soy protein source. The resulting clarified aqueous soy protein solution may be diluted and the pH adjusted within the range of 1.5-5.0. The solution may be concentrated by ultrafiltration, diafiltered and then dried to provide the soy protein product. Alternatively, the concentrated and optionally diafiltered soy protein solution may be optionally adjusted in pH within the range of 1.5-7.0 then diluted into water to cause the formation of a precipitate, separating the precipitate from the diluting water (supernatant) and drying the separated soy protein to form a soy protein product having a protein content of at least about 60 wt % (N×6.25) d.b., preferably a soy protein isolate having a protein content of at least about 90 wt % (N×6.25) d.b. The supernatant may be processed to form soy protein products having a protein content of at least about 60 wt % (N×6.25) d.b., preferably a soy protein isolate having a protein content of at least 90 wt % (N×6.25) d.b. Alternatively, the precipitate from the dilution step may be re-solubilized in the diluting water by adjustment of the pH to resolubilize the precipitate and form a protein solution. The soy protein solution may be concentrated while maintaining the ionic strength substantially constant by using a selective membrane technique followed by optional diafiltration and drying. The soy protein product is soluble in acidic medium and produces transparent, heat stable solutions and hence may be used for protein fortification of soft drinks and sports drinks. | 2011-09-15 |
20110223296 | SANDWICH COOKING ACCESSORY - Disclosed is a sandwich cooking accessory having a plurality of pockets in which may be assembled a sandwich or into which may be placed a raw (not yet cooked) sandwich. The accessory also includes a panel engagable to the pockets to contain the assembled sandwiches during handling and cooking. The panel cooperates with the pockets to slightly, but not excessively, compress the sandwiches. The pockets and panel are perforated to enable heat to the sandwiches during cooking. The panel include a plurality of shield to protect certain portions of the sandwiches from excessive toasting during cooking. | 2011-09-15 |
20110223297 | Anti-Caking Agent for Flavored Products - The present invention generally relates to the use of porous particles to control the release of a liquid, such as the release of a flavor in a food product. Liquid components, such as flavorants, are loaded into porous particles to form a composition. The pore diameter, pore tortuosity and loading parameters determine the characteristics of the composition and the release profile of the liquid. | 2011-09-15 |
20110223298 | SELENIUM COVERED BASIC COPPER CHLORIDE, ITS PREPARATION METHOD AND THE USE - A preparation method for selenium covered basic copper chloride includes the steps of: (a) adding crystalline basic copper chloride (TBCC), water and stabilizer in a reactor; adding sodium hydroxide solution with stirring; reacting to form a hydroxyl-modified crystalline basic copper chloride after discharge, washing, and negative pressure leaching; (b) adding the hydroxyl-modified crystalline basic copper chloride and water in the reactor, adding selenous acid with stirring; adding copper sulfate pentahydrate after reaction; forming selenium covered basic copper chloride comprising crystalline basic copper chloride, basic cuprous selenide, and basic cupric sulfate after discharge, rinsing, negative pressure filtration, and drying. The selenium covered basic copper chloride is used as feed addictives of trace elements having nonhygroscopic property, good liquidity, and stable chemical property. The selenium covered basic copper chloride is easy to incorporate with feed, low price, low cost in adding, weak acidic solubility, easy to absorb. | 2011-09-15 |
20110223299 | Using squeezable containers for baby food to feed babies - SDDR Corporation (which was incorporated on Jan. | 2011-09-15 |
20110223300 | Food holding device, method of making, and method of storing cooked food - A food holding device includes a holding bin and an optional heating component. The holding bin has a specified average surface roughness Ra on at least a portion of the surface intended to be contacted with food during storage of the food. | 2011-09-15 |
20110223301 | Methods for Reducing Soluble Metal Ions in Diatomaceous Earth Filter Aids - A method for reducing the amount of beverage soluble metal ions in a diatomaceous earth filter aid is disclosed. The beverage soluble metal ions can be copper and/or iron. In the method, the diatomaceous earth filter aid is contacted with a hop compound selected from iso-alpha-acids, dihydroiso-alpha-acids, tetrahydroiso-alpha-acids, hexahydroiso-alpha-acids, alpha-acids, and beta-acids. The diatomaceous earth filter aid can also be contacted with and an acid other than the hop compound such as phosphoric acid. The iso-alpha-acids, dihydroiso-alpha-acids, tetrahydroiso-alpha-acids, hexahydroiso-alpha-acids, alpha-acids, or beta-acids bind the copper and iron metal ions and/or change the form of copper and iron in diatomaceous earth so the copper and iron are rendered substantially insoluble in a beverage such as beer. A method for filtering a beverage using the treated diatomaceous earth filter aid is also disclosed. A method for increasing the flavor stability of a malt beverage filtered with a diatomaceous earth filter aid is also disclosed. | 2011-09-15 |
20110223302 | BEVERAGE BREWING APPARATUS WITH A FILTER CARRIER RECEIVER - A beverage maker is disclosed with a removable filter carrier, a receiver for the removable filter carrier, and a locking mechanism to selectively secure and seal the carrier to the beverage maker by way of lifting the carrier to engage a sealing surface. In use, the filter carrier is linearly inserted into the receiver via a front face of the beverage maker. The receiver may also include the locking mechanism. The locking mechanism includes a lever that is actuated to operate the locking mechanism. Actuation of the lever is translated to lift and clamp the filter carrier against the seal surface. In the ‘sealed’ position, the lever is selectively fixed in place until the user actuates the lever so as to release the filter carrier. In the ‘released’ position, the filter carrier is still supported by the locking mechanism but it may be selectively removed from the receiver. The locking mechanism reduces or eliminates conventional issues with securing a filter carrier to a beverage maker such as properly aligning the filter carrier so that it may be secured to the beverage maker, the filter carrier disengaging from the beverage maker during use, or not being able to remove the filter carrier after a brew cycle. | 2011-09-15 |
20110223303 | RESISTANCE GENES - The present invention relates to polynucleotides encoding adult plant pathogen resistance proteins. Also provided are transgenic plants expressing these polynucleotides to enhance the resistance of the plants to pathogens. | 2011-09-15 |
20110223304 | Production Of Whole Grain Shredded Products - Shredded whole grain products, such as ready-to-eat cereals, and sweet and savory snacks, such as whole grain shredded corn chips are continuously produced by pelletizing agglomerates of cooked, tempered, whole cereal grain particles. Cooked whole grains, such as corn and other non-gluten or low-gluten containing grains have a tendency to become hard and rubbery after cooking during the cooling and tempering process. The pelletization results in the production of whole grain pellets having a soft, pliable texture, which are shreddable into continuous net-like sheets on a mass production basis. The pelletizing may be at a pressure of about 200 psig to about 600 psig, preferably from about 400 psig to about 500 psig. The pelletizing temperature may be controlled to provide a pellet temperature of about 80° F. to about 135° F., preferably from about 90° F. to about 110° F., upon exiting the pelletizer. | 2011-09-15 |
20110223305 | ERGONOMIC FOOD SCOOP AND METHOD - An ergonomic food scoop may comprise a scoop bowl, a hand grip and a wrist support. A support member may interconnect the bowl and the hand grip and may be oriented perpendicular to the hand grip. The wrist support may be oriented parallel to the hand grip. One or more hand grip connectors may connect the hand grip to the wrist support. | 2011-09-15 |
20110223306 | FOOD PREPARATION DEVICE - A food preparation device including: a body defining a passage; and a mount or head portion for holding a skewer within the passage. The passage has an opening for receiving portions of food such that when a skewer is held by the mount, portions of food entering the opening become impaled on the skewer within the passage. The device is provided with a cutter to cut portions of food such as meat for use in the device. | 2011-09-15 |
20110223307 | EXTRACTED WHOLE CORN KERNELS AND IMPROVED PROCESSED AND PROCESSABLE CORN PRODUCED THEREBY - A processed corn kernel product is obtained from an extraction process in which:
| 2011-09-15 |
20110223308 | Machine and process for producing a solid alcohol product - A process and apparatus for producing a solid, edible ethanol containing product which may be either a rubbery solid or a hard solid that is frozen about 24.8° F. (−4° C.). The product contains agar and gelatin and the ethanol may be provided in the form of selected alcoholic beverages. | 2011-09-15 |
20110223309 | METHOD AND DEVICE FOR CREMA PRODUCTION BASED ON VOLUMETRIC FLOW - A method for producing crema in a coffee vending machine that has a flow-through heater for heating water and that is charged with substrate capsules which include a Venturi nozzle for crema production. The method includes a) heating the water in the flow-through heater; b) brewing ground coffee using the heated water in a brewing chamber in order to produce a coffee drink; and c) producing crema by mixing the coffee drink with a gas in the Venturi nozzle. In step c), at least one of two volumetric flows of the coffee drink or the gas is increased in the Venturi nozzle during a predetermined time interval. | 2011-09-15 |